Galmed Pharmaceuticals (GLMD) Other Working Capital Changes (2016 - 2018)

Galmed Pharmaceuticals (GLMD) posted quarterly Other Working Capital Changes of -$274000.0 for Q4 2016.

Galmed Pharmaceuticals (GLMD) Other Working Capital Changes (2016 - 2018) Analysis & Trends

Galmed Pharmaceuticals' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at -$270000.0 for Q2 2018.

In Q2 2018, Other Working Capital Changes changed 0.0% year-over-year to -$270000.0; the TTM figure through Dec 2018 stood at -$538000.0 (up 50.41% YoY), while the FY2018 annual figure was -$538000.0, up 50.41% from the prior year.
Other Working Capital Changes for Q4 2016 stood at -$274000.0.
The five-year high for Other Working Capital Changes was $1.9 million in Q3 2016, with the low at -$274000.0 in Q4 2016.
The 3-year median for Other Working Capital Changes is -$270000.0 (2017), against an average of $0.0.
Peak annual rise in Other Working Capital Changes reached 0.36% in 2017, while the deepest fall reached 114.44% in 2017.
Galmed Pharmaceuticals' Other Working Capital Changes stood at -$274000.0 in 2016, then grew by 0.36% to -$273000.0 in 2017, then increased by 1.1% to -$270000.0 in 2018.
Business Quant data shows GLMD's Other Working Capital Changes at -$270000.0 in Q2 2018, -$268000.0 in Q1 2018, and -$273000.0 in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Galmed Pharmaceuticals	2.31 Mn	-9.57 Mn	-

Download Data